[Form 4] HNI Corporation Insider Trading Activity
Rhea-AI Filing Summary
HNI Corporation (HNI) – Form 4 insider transaction
Director Miguel M. Calado reported the sale of 1,743 HNI common shares on 07/24/2025 at a stated price of $53 per share. The trade was made under a Rule 10b5-1 plan adopted on 03/04/2025, indicating it was pre-scheduled. Following the sale, Calado’s direct ownership stands at 30,085.415 shares. No derivative security transactions were reported.
The filing shows an approximate reduction of about 5.5 % of Calado’s direct position (1,743 ÷ 31,828.415 pre-sale shares). Other than the transaction details, the Form 4 does not include additional financial or strategic disclosures.
Positive
- Pre-scheduled under Rule 10b5-1, lessening concerns about opportunistic trading or negative undisclosed information.
Negative
- Director reduced holdings by approximately 5.5 %, which some investors may interpret as diminished insider confidence.
Insights
TL;DR: Director sells 5.5 % stake via 10b5-1 plan; modestly negative signal but pre-planned limits interpretation.
The reported 1,743-share sale trims Miguel Calado’s directly held HNI stake to roughly 30k shares. While insider selling can hint at weaker conviction, the use of a Rule 10b5-1 plan reduces the likelihood of information asymmetry or opportunistic timing. No other insiders or derivative transactions are listed, suggesting this is an isolated, routine liquidity event. Impact on share supply is immaterial (<0.01 % of outstanding shares), yet investors often view any director-level selling as a mild negative sentiment indicator.